Wed 08 Nov 2017 |
|
| The Accelerated Access Review has completed its work and published a paper. The Government is broadly accepting the recommendations of the review which will mean some pharamceuticals and medical devices will now be given accelerated "breakthrough" status. These products will now receive support and fast tracking through the system enabling patients to benefit from breakthrough technologies faster. To read this paper in full and discover its implications for your organisation please visit the link here. |
